RxDoctor Payments Data

Kary Morford

Psychiatric/Mental Health · Indianapolis, INNPI 1457534067

Payments from drug & device makers

$1,984in general payments, 2019–2025

Across 100 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$455
  • Alkermes, Inc.$440
  • Otsuka America Pharmaceutical, Inc.$245
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$217
  • Corium, LLC$166
  • Teva Pharmaceuticals USA, Inc.$124
  • plus $338 from 11 others

What the payments were for

  • Food & beverage$1,93798%
  • Education$472%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,984 in reported general payments places this provider in the 70th percentile of 729 psychiatric/mental health providers in Indiana.

See all psychiatric/mental health providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate13$106,960
VraylarCariprazine Hcl44$60,180
Abilify MaintenaAripiprazole13$35,872
RexultiBrexpiprazole23$32,971
TrintellixVortioxetine Hydrobromide14$7,633
Aripiprazole31$4,455
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine17$1,536
Sertraline Hcl19$1,386
Duloxetine Hcl54$1,308
Prazosin Hcl51$1,082
Bupropion XlBupropion Hcl50$1,051
Quetiapine Fumarate ErQuetiapine Fumarate13$834
Clonazepam33$613
Escitalopram Oxalate42$527
Mirtazapine22$427

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$54$106,96013 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$245$68,84336 claims
AbbVieVraylar$455$60,18044 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$18$7,63314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 729 psychiatric/mental health providers in Indiana.

Other psychiatric/mental health in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →